PURPOSE: This study assessed the levels of depressive symptomatology in African-American women with breast cancer compared to those of women without breast cancer and examined demographic, psychosocial, and clinical factors correlated with depression. METHODS: A total of 152 African-American women were recruited from Washington, DC and surrounding suburbs. Breast cancer patients (n = 76 cases) were recruited from a health care center and women without cancer were recruited from health fairs (n = 76 comparison). We assessed depression, psychosocial variables (ego strength and social support), and sociodemographic factors from in-person interviews. Stage and clinical factors were abstracted from medical records. Independent sample t test, chi square test, analyses of variance, and multiple regression models were used to identify differences in depression and correlates of depression among the cases and comparison groups. RESULTS: Women with breast cancer reported significantly greater levels of depression (m = 11.5, SD = 5.0) than women without breast cancer (m = 3.9, SD = 3.8) (p < 0.001). Higher cancer stage (beta = 0.91) and higher age (beta = 0.11) were associated with depression in the breast patients, explaining 84 % of the variance. In the comparison group, ego strength and tangible support were inversely associated with depressive symptoms, accounting for 32 % of the variance. CONCLUSIONS: Women with more advanced disease may require interdisciplinary approaches to cancer care (i.e., caring for the whole person). IMPLICATIONS FOR CANCER SURVIVORS: Depression is often underrecognized and undertreated in African-American breast cancer patients. Understanding the factors related to depression is necessary to integrate psychosocial needs to routine cancer care to improve survivors' quality of life.
PURPOSE: This study assessed the levels of depressive symptomatology in African-American women with breast cancer compared to those of women without breast cancer and examined demographic, psychosocial, and clinical factors correlated with depression. METHODS: A total of 152 African-American women were recruited from Washington, DC and surrounding suburbs. Breast cancerpatients (n = 76 cases) were recruited from a health care center and women without cancer were recruited from health fairs (n = 76 comparison). We assessed depression, psychosocial variables (ego strength and social support), and sociodemographic factors from in-person interviews. Stage and clinical factors were abstracted from medical records. Independent sample t test, chi square test, analyses of variance, and multiple regression models were used to identify differences in depression and correlates of depression among the cases and comparison groups. RESULTS:Women with breast cancer reported significantly greater levels of depression (m = 11.5, SD = 5.0) than women without breast cancer (m = 3.9, SD = 3.8) (p < 0.001). Higher cancer stage (beta = 0.91) and higher age (beta = 0.11) were associated with depression in the breastpatients, explaining 84 % of the variance. In the comparison group, ego strength and tangible support were inversely associated with depressive symptoms, accounting for 32 % of the variance. CONCLUSIONS:Women with more advanced disease may require interdisciplinary approaches to cancer care (i.e., caring for the whole person). IMPLICATIONS FOR CANCER SURVIVORS: Depression is often underrecognized and undertreated in African-American breast cancerpatients. Understanding the factors related to depression is necessary to integrate psychosocial needs to routine cancer care to improve survivors' quality of life.
Authors: Kyaien O Conner; Brenda Lee; Vanessa Mayers; Deborah Robinson; Charles F Reynolds; Steve Albert; Charlotte Brown Journal: J Aging Stud Date: 2010-12-01
Authors: Brenda L Den Oudsten; Guus L Van Heck; Alida F W Van der Steeg; Jan A Roukema; Jolanda De Vries Journal: Support Care Cancer Date: 2009-08-16 Impact factor: 3.603
Authors: Marlyn Allicock; Lindsey Haynes-Maslow; La-Shell Johnson; William R Carpenter; Anissa I Vines; Denise G Belle; Ray Phillips; Michele W Cherry Journal: Transl Behav Med Date: 2017-09 Impact factor: 3.046
Authors: Jennifer C Plumb Vilardaga; Hannah M Fisher; Joseph G Winger; Shannon N Miller; Christine Nuñez; Catherine Majestic; Sarah A Kelleher; Tamara J Somers Journal: Support Care Cancer Date: 2022-05-02 Impact factor: 3.359
Authors: Cleo A Samuel; Laura C Pinheiro; Katherine E Reeder-Hayes; Jennifer S Walker; Giselle Corbie-Smith; Shekinah A Fashaw; Cheryl Woods-Giscombe; Stephanie B Wheeler Journal: Breast Cancer Res Treat Date: 2016-09-06 Impact factor: 4.872
Authors: Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Tiffany L Carson; Jesse J Plascak; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos Journal: Breast Cancer Res Treat Date: 2020-09-10 Impact factor: 4.872
Authors: Theresa A Hastert; Jean A McDougall; Shaila M Strayhorn; Mrudula Nair; Jennifer L Beebe-Dimmer; Ann G Schwartz Journal: Cancer Date: 2020-11-23 Impact factor: 6.860
Authors: Annelise A Madison; Juan Peng; M Rosie Shrout; Megan E Renna; Catherine M Alfano; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; William E Carson; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychoneuroendocrinology Date: 2021-05-27 Impact factor: 4.693